Synairgen (SNG) Competitors GBX 0.92 -0.03 (-2.63%) As of 04/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock SNG vs. TRX, COS, C4XD, DDDD, FUM, SAR, OKYO, AOR, OPTI, and ARECShould you be buying Synairgen stock or one of its competitors? The main competitors of Synairgen include Tissue Regenix Group (TRX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Futura Medical (FUM), Sareum (SAR), OKYO Pharma (OKYO), AorTech International (AOR), OptiBiotix Health (OPTI), and Arecor Therapeutics (AREC). These companies are all part of the "biotechnology" industry. Synairgen vs. Tissue Regenix Group Collagen Solutions plc (COS.L) C4X Discovery 4D pharma Futura Medical Sareum OKYO Pharma AorTech International OptiBiotix Health Arecor Therapeutics Tissue Regenix Group (LON:TRX) and Synairgen (LON:SNG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability, valuation and community ranking. Which has more volatility & risk, TRX or SNG? Tissue Regenix Group has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500. Comparatively, Synairgen has a beta of -2.23, meaning that its share price is 323% less volatile than the S&P 500. Which has higher valuation & earnings, TRX or SNG? Tissue Regenix Group has higher revenue and earnings than Synairgen. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Synairgen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTissue Regenix Group£31.98M1.03-£1.11M-£0.97-37.58SynairgenN/AN/A-£15.86M-£1.66-0.56 Do institutionals and insiders hold more shares of TRX or SNG? 37.0% of Tissue Regenix Group shares are held by institutional investors. Comparatively, 30.7% of Synairgen shares are held by institutional investors. 47.3% of Tissue Regenix Group shares are held by company insiders. Comparatively, 3.2% of Synairgen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in TRX or SNG? Tissue Regenix Group received 9 more outperform votes than Synairgen when rated by MarketBeat users. Likewise, 69.53% of users gave Tissue Regenix Group an outperform vote while only 56.46% of users gave Synairgen an outperform vote. CompanyUnderperformOutperformTissue Regenix GroupOutperform Votes16269.53% Underperform Votes7130.47% SynairgenOutperform Votes15356.46% Underperform Votes11843.54% Does the media favor TRX or SNG? In the previous week, Tissue Regenix Group's average media sentiment score of 0.00 equaled Synairgen'saverage media sentiment score. Company Overall Sentiment Tissue Regenix Group Neutral Synairgen Neutral Is TRX or SNG more profitable? Synairgen has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -3.46%. Tissue Regenix Group's return on equity of -2.87% beat Synairgen's return on equity.Company Net Margins Return on Equity Return on Assets Tissue Regenix Group-3.46% -2.87% 0.50% Synairgen N/A -29.40%-30.58% SummaryTissue Regenix Group beats Synairgen on 10 of the 12 factors compared between the two stocks. Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNG vs. The Competition Export to ExcelMetricSynairgenBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£9.04M£120.88M£5.31B£2.52BDividend Yield1.53%3.76%5.45%4.80%P/E Ratio-0.563.0521.94131.32Price / SalesN/A4,157.44380.66235,334.67Price / Cash1.9013.0538.2528.39Price / Book0.1934.176.454.43Net Income-£15.86M-£91.72M£3.22B£5.89B7 Day PerformanceN/A1.39%0.74%1.32%1 Month Performance-6.57%-6.39%-9.66%-0.52%1 Year Performance-86.30%84.27%11.81%22.48% Synairgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNGSynairgenN/AGBX 0.93-2.6%N/A-86.3%£9.04MN/A-0.5634Gap DownTRXTissue Regenix GroupN/AGBX 36-1.4%N/A-40.8%£32.46M£31.98M-37.17120COSCollagen Solutions plc (COS.L)N/AN/AN/AN/A£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AN/AN/AN/A£30.05M£718,000.00-1.08106FUMFutura MedicalN/AGBX 9.60-0.4%N/A-75.1%£29.92M£8.68M-7.9212Earnings ReportSARSareumN/AGBX 19flatN/AN/A£23.74MN/A-4.503,211Gap UpOKYOOKYO PharmaN/AN/AN/AN/A£23.24MN/A-140.007Gap DownAORAorTech InternationalN/AN/AN/AN/A£19.99M£539,000.00-33.383OPTIOptiBiotix HealthN/AGBX 17.62+0.7%N/A+2.8%£17.26M£590,009.23-5.581ARECArecor TherapeuticsN/AGBX 38.50+1.3%N/A-69.3%£14.54M£6.04M-1.3610Gap UpHigh Trading Volume Related Companies and Tools Related Companies Tissue Regenix Group Competitors Collagen Solutions plc (COS.L) Competitors C4X Discovery Competitors 4D pharma Competitors Futura Medical Competitors Sareum Competitors OKYO Pharma Competitors AorTech International Competitors OptiBiotix Health Competitors Arecor Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SNG) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synairgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNG Stock Free SNG Stock Alerts